Skip to main content

Pirin Antibody (4D1)

Novus Biologicals, part of Bio-Techne | Catalog # H00008544-M03

Novus Biologicals, part of Bio-Techne
Catalog #
Availability
Size / Price
Qty
Loading...
H00008544-M03

Key Product Details

Species Reactivity

Human

Applications

ELISA, Knockdown Validated, Western Blot

Label

Unconjugated

Antibody Source

Monoclonal Mouse IgG2a Kappa Clone # 4D1

Concentration

Concentrations vary lot to lot. See vial label for concentration. If unlisted please contact technical services.

Product Specifications

Immunogen

PIR (AAH02517, 1 a.a. ~ 290 a.a) full-length recombinant protein with GST tag. MW of the GST tag alone is 26 KDa. MGSSKKVTLSVLSREQSEGVGARVRRSIGRPELKNLDPFLLFDEFKGGRPGGFPDHPHRGFETVSYLLEGGSMAHEDFCGHTGKMNPGDLQWMTAGRGILHAEMPCSEEPAHGLQLWVNLRSSEKMVEPQYQELKSEEIPKPSKDGVTVAVISGEALGIKSKVYTRTPTLYLDFKLDPGAKHSQPIPKGWTSFIYTISGDVYIGPDDAQQKIEPHHTAVLGEGDSVQVENKDPKRSHFVLIAGEPLREPVIQHGPFVMNTNEEISQAILDFRNAKNGFERAKTRKSKIGN

Specificity

PIR (4D1)

Clonality

Monoclonal

Host

Mouse

Isotype

IgG2a Kappa

Description

Quality control test: Antibody Reactive Against Recombinant Protein.

Scientific Data Images for Pirin Antibody (4D1)

Western Blot: Pirin Antibody (4D1) [H00008544-M03]

Western Blot: Pirin Antibody (4D1) [H00008544-M03]

Western Blot: Pirin Antibody (4D1) [H00008544-M03] - Analysis of PIR expression in transfected 293T cell line by PIR monoclonal antibody (M03), clone 4D1. Lane 1: PIR transfected lysatE (32.113 KDa). Lane 2: Non-transfected lysate.
Western Blot: Pirin Antibody (4D1) [H00008544-M03]

Western Blot: Pirin Antibody (4D1) [H00008544-M03]

Western Blot: Pirin Antibody (4D1) [H00008544-M03] - Western blot analysis of PIR over-expressed 293 cell line, cotransfected with PIR Validated Chimera RNAi or non-transfected control. Blot probed with H00008544-M03. GAPDH (36.1 kDa) used as loading control.

Applications for Pirin Antibody (4D1)

Application
Recommended Usage

ELISA

Optimal dilutions of this antibody should be experimentally determined.

Knockdown Validated

Optimal dilutions of this antibody should be experimentally determined.

Western Blot

Optimal dilutions of this antibody should be experimentally determined.
Application Notes
Antibody reactivity against transfected lysate and recombinant protein for WB. It has been used for ELISA and RNAi Validation.

Formulation, Preparation, and Storage

Purification

IgG purified

Formulation

In 1x PBS, pH 7.4

Preservative

No Preservative

Concentration

Concentrations vary lot to lot. See vial label for concentration. If unlisted please contact technical services.

Shipping

The product is shipped with polar packs. Upon receipt, store it immediately at the temperature recommended below.

Stability & Storage

Aliquot and store at -20C or -80C. Avoid freeze-thaw cycles.

Background: Pirin

This gene encodes a member of the cupin superfamily. The encoded protein is an Fe(II)-containing nuclear protein expressed in all tissues of the body and concentrated within dot-like subnuclear structures. Interactions with nuclear factor I/CCAAT box transcription factor as well as B cell lymphoma 3-encoded oncoprotein suggest the encoded protein may act as a transcriptional cofactor and be involved in the regulation of DNA transcription and replication. Alternatively spliced transcript variants have been described.

Alternate Names

EC 1.13.11.24, pirin, pirin (iron-binding nuclear protein), Probable quercetin 2,3-dioxygenase PIR, Probable quercetinase

Entrez Gene IDs

8544 (Human)

Gene Symbol

PIR

OMIM

603329 (Human)

Additional Pirin Products

Product Documents for Pirin Antibody (4D1)

Certificate of Analysis

To download a Certificate of Analysis, please enter a lot number in the search box below.

Product Specific Notices for Pirin Antibody (4D1)

This product is produced by and distributed for Abnova, a company based in Taiwan.

This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.

Loading...
Loading...
Loading...
Loading...